Publisher
The Nihon University Medical Association
Reference40 articles.
1. 1) Takei M, Kitamura N, Shiraiwa H, et al. The possible curative therapy for rheumatoid arthritis-EBV infection control gene SAP and its application. Nihon Rinsho Meneki Gakkai Kaishi 2008; 31: 141-151.
2. 2) Alspaugh MA, Jensen FC, Rabin H, et al. Lymphocyte transformed by Epstein-Barr virus: induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 1978; 147: 1018-1027.
3. 3) Billings PB, Hoch SO, White PJ, et al. Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci 1983; 80: 7104-7108.
4. 4) Rhodes G, Carson DA, Valbracht J, et al. Human immune response to synthetic peptides from the Epstein-Barr virus nuclear antigen. J Immunol 1985; 134: 211-216.
5. 5) Rumpold H, Rhodes GH, Bloch PL, et al. The glycinealanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). J Immunol 1987; 138: 593-599.